LambdaVision: LambdaVision Holds First Closing of Seed Funding

LambdaVision, a CT-based biotech company developing a protein-based artificial retina technology, closed its first Seed funding. The round was led by Aurelia Foundry Fund, a fund spun out of MIT. Other investors included Boryung, a publicly listed Korean pharmaceutical company, and E2MC Ventures. The company intends to use the funds to accelerate its GMP manufacturing [...]The post LambdaVision Holds First Closing of Seed Funding appeared first on FinSMEs.